Research progress in diagnosis and treatment of mild traumatic brain injury and posttraumatic stress disorder comorbidity in the soldiers
10.3760/cma.j.issn.1001-8050.2020.08.011
- VernacularTitle:军人创伤后应激障碍和轻度创伤性脑损伤共病诊治的研究进展
- Author:
Yue LI
1
;
Bingcang LI
Author Information
1. 空军军医大学西京医院神经外科，西安 710054
- From:
Chinese Journal of Trauma
2020;36(8):729-735
- CountryChina
- Language:Chinese
-
Abstract:
Posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) are the signature injuries of modern war. The comorbidity rate of PTSD and mTBI in American and British soldiers is 23% and 33%-36%, respectively. At present, there is no early diagnosis methods, specific treatment methods or drugs, which seriously affects the combat effectiveness of the army. The authors summarize the clinical and basic researches in recent years from incidence, comorbidity, clinical manifestations, diagnostic and treatment methods in an attempt to offer a reference for the treatment of PTSD and mTBI in soldiers.
